dm+d
Unassigned
New Medicines
Acne vulgaris
Information
New formulation
Not Known
Novan
Development and Regulatory status
None
None
Phase III Clinical Trials
Category
A topical gel containing NVN 1000, a nitric oxide-releasing macromolecule that comprises a polysiloxane backbone with covalently bound N diazeniumdiolate nitric oxide donors
Almost every teenager can expect to experience acne to some degree during the adolescent years although it is usually mild. Moderate-to-severe acne affects about 20% of young people [1].
Acne vulgaris
Topical